Sanyou生物制药公司于2026年启动了一个创新枢纽,利用先进的抗体图书馆和全球研发资源加快生物药物开发。 Sanyou Biopharmaceuticals launched an innovation hub in 2026 to accelerate biologic drug development using advanced antibody libraries and global R&D resources.

2026年,Lang Guojun于2015年创立的Sanyou生物制药公司启动了其原药发现创新中心,这是一个平台,将智慧超强抗体图书馆与全球研发资源结合起来,以加速生物药物开发。 In 2026, Sanyou Biopharmaceuticals, founded in 2015 by Lang Guojun, launched its Innovation Hub for Original Drug Discovery, a platform integrating its Intelligent Super-Trillion Antibody Library with global R&D resources to accelerate biologic drug development. 该枢纽提供了药物发现、临床前期发展和工业化的端到端解决方案,反映了该公司从一个拥有100平方米实验室的小型启动企业演变为中国生物制药创新的主要力量,得到了20,000平方米以上的设施和可持续商业模式的支持。 The hub offers end-to-end solutions in drug discovery, preclinical development, and industrialization, reflecting the company’s evolution from a small startup with a 100-square-meter lab to a major force in China’s biopharma innovation, supported by over 20,000 square meters of facilities and a sustainable business model.